Trial intelligence / Profile preview

Progesterone and Resting Energy Expenditure in Menopausal Transition

NCT04140968Phase 4Terminated

Sponsor
Insel Gruppe
Start
Nov 2019
Primary completion
May 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of progesterone in menopausal transition, sponsored by Insel Gruppe. Started Nov 2019; status: terminated.

02

Drugs

progesterone
03

Conditions

menopausal transition

Beyond the preview

Go deeper on NCT04140968.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04140968.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call